Influence of hepatitis B virus genotypes on the response to antiviral therapies

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 2, 2005, Pages 139-142

  Akuta, Norio ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Chronic hepatitis; Genotypes; Hepatitis B e antigen; Hepatitis B virus; Interferon; Lamivudine

Indexed keywords

ADEFOVIR DIPIVOXIL; ANTIVIRUS AGENT; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; PLACEBO;

ANTIGEN EXPRESSION; ARTICLE; ASIA; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HETEROZYGOTE; HUMAN; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS CLASSIFICATION; VIRUS GENOME; VIRUS RECOMBINATION; VIRUS RESISTANCE;

ANIMALS; ANTIVIRAL AGENTS; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS;

EID: 14744286050     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh533     Document Type: Article

References (52)

1. Lee, W. M. (1997). Hepatitis B virus infection. New England Journal of Medicine 337, 1733-45.
2. Okamoto, H., Tsuda, F., Sakugawa, H. et al. (1988). Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. Journal of General Virology 69, 2575-83.
3. Norder, H., Courouce, A. M. & Magnius, L. O. (1994). Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198, 489-503.
4. Stuyver, L., De Gendt, S., Van Geyt, C. et al. (2000). A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. Journal of General Virology 81, 67-74.
5. Arauz-Ruiz, P., Norder, H., Robertson, B. H. et al. (2002). Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. Journal of General Virology 83, 2059-73.
6. Miyakawa, Y. & Mizokami, M. (2003). Classifying hepatitis B virus genotypes. Intervirology 46, 329-38.
7. Kao, J. H., Chen, P. J., Lai, M. Y. et al. (2000). Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118, 554-9.
8. Orito, E., Mizokami, M., Sakugawa, H. et al. (2001). A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Hepatology 33 218-23.
9. Chu, C. J., Hussain, M. & Lok, A. S. (2002). Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 122, 1756-62.
10. Nakayoshi, T., Maeshiro, T., Nakasone, H. et al. (2003). Difference in prognosis between patients infected with hepatitis B virus with genotype B and those with genotype C in the Okinawa Islands: a prospective study. Journal of Medical Virology 70, 350-4.
11. Tsubota, A., Arase, Y., Ren, F. et al. (2001). Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw. Journal of Medical Virology 65, 257-65.
12. Fujie, H., Moriya, K., Shintani, Y. et al. (2001). Hepatitis B virus genotypes and hepatocellular carcinoma in Japan. Gastroenterology 120, 1564-5.
13. Lee, C. M., Chen, C. H., Lu, S. N. et al. (2003). Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan. Scandinavian Journal of Gastroenterology 38, 95-101.
14. Duong, T. N., Horiike, N., Michitaka, K. et al. (2004). Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study. Journal of Medical Virology 72, 551-7.
15. Miyakawa, Y., Okamoto, H. & Mayumi, M. (1997). The molecular basis of hepatitis B e antigen (HBeAg)-negative infections. Journal of Viral Hepatitis 4, 1-8.
16. Li, J. S., Tong, S. P., Wen, Y. M. et al. (1993). Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. Journal of Virology 67, 5402-10.
17. Sugauchi, F., Orito, E., Ichida, T. et al. (2002). Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. Journal of Virology 76, 5985-92.
18. Sugauchi, F., Orito, E., Ichida, T. et al. (2003). Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology 124 925-32.
19. Mayerat, C., Mantegani, A. & Frei, P. C. (1999). Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? Journal of Viral Hepatitis 6, 299-304.
20. Sanchez-Tapias, J. M., Costa, J., Mas, A. et al. (2002). Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology 123 1848-56.
21. Thakur, V., Guptan, R. C., Kazim, S. N. et al. (2002). Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. Journal of Gastroenterology and Hepatology 17, 165-70.
22. Kobayashi, M., Arase, Y., Ikeda, K. et al. (2002). Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in Japan. Journal of Medical Virology 68, 522-8.
23. Dooley, J. S., Davis, G. L., Peters, M. et al. (1986). Pilot study of recombinant human alpha-interferon for chronic type B hepatitis. Gastroenterology 90, 150-7.
24. Hoofnagle, J. H., Peters, M., Mullen, K. D. et al. (1988). Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology 95, 1318-25.
25. Wong, D. K., Cheung, A. M., O'Rourke, K. et al. (1993). Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Annals of Internal Medicine 119, 312-23.
26. Liaw, Y. F., Leung, N., Guan, R. et al. (2003). Asian-Pacific consensus statement on the management of chronic hepatitis B: an update. Journal of Gastroenterology and Hepatology 18, 239-45.
27. Brunetto, M. R., Giarin, M. M., Oliveri, F. et al. (1991). Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proceedings of the National Academy of Sciences, USA 88, 4186-90.
28. Zhang, X., Zoulim, F., Habersetzer, F. et al. (1996). Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B. Journal of Medical Virology 48, 8-16.
29. Kao, J. H., Wu, N. H., Chen, P. J. et al. (2000). Hepatitis B genotypes and the response to interferon therapy. Journal of Hepatology 33, 998-1002.
30. Wai, C. T., Chu, C. J., Hussain, M. et al. (2002). HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Hepatology 36, 1425-30.
31. Nevens, F., Main, J., Honkoop, P. et al. (1997). Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology 113, 1258-63.
32. Lai, C. L., Ching, C. K., Tung, A. K. et al. (1997). Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology 25, 241-4.
33. Suzuki, Y., Kumada, H., Ikeda, K. et al. (1999). Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection. Journal of Hepatology 30, 743-8.
34. Dienstag, J. L., Schiff, E. R., Wright, T. L. et al. (1999). Lamivudine as initial treatment for chronic hepatitis B in the United States. New England Journal of Medicine 341, 1256-63.
35. Liaw, Y. F., Leung, N. W., Chang, T. T. et al. (2000). Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Gastroenterology 119, 172-80.
36. Suzuki, F., Suzuki, Y., Tsubota, A. et al. (2002). Mutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy. Journal of Hepatology 37 824-30.
37. Suzuki, Y., Arase, Y., Ikeda, K. et al. (2003). Histological improvements after a three-year lamivudine therapy in patients with chronic hepatitis B in whom YMDD mutants did not or did develop. Intervirology 46, 164-70.
38. Suzuki, F., Tsubota, A., Arase, Y. et al. (2003). Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan. Intervirology 46, 182-9.
39. Kumada, H. (2004). Lamivudine for patients with chronic hepatitis B: how long? Journal of Gastroenterology, in press.
40. Kumada, H. (2003). Continued lamivudine therapy in patients with chronic hepatitis B. Intervirology 46, 377-87.
41. Kao, J. H., Liu, C. J. & Chen, D. S. (2002). Hepatitis B viral genotypes and lamivudine resistance. Journal of Hepatology 36, 303-4.
42. Chien, R. N., Yeh, C. T., Tsai, S. L. et al. (2003). Determinants for sustained HBeAg response to lamivudine therapy. Hepatology 38, 1267-73.
43. Akuta, N., Suzuki, F., Kobayashi, M. et al. (2003). The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment. Journal of Hepatology 38 315-21.
44. Zollner, B., Petersen, J., Schroter, M. et al. (2001). 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw. Lancet 357, 934-5.
45. Zollner, B., Petersen, J., Puchhammer-Stockl, E. et al. (2004). Viral features of lamivudine resistant hepatitis B genotypes A and D. Hepatology 39, 42-50.
46. Qaqish, R. B., Mattes, K. A. & Ritchie, D. J. (2003). Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection. Clinical Therapeutics 25, 3084-99.
47. Angus, P., Vaughan, R., Xiong, S. et al. (2003). Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 125, 292-7.
48. Westland, C., Delaney, W. T., Yang, H. et al. (2003). Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil. Gastroenterology 125 107-16.
49. Sumi, H., Yokosuka, O., Seki, N. et al. (2003). Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 37, 19-26.
50. Yuen, M. F., Wong, D. K., Sablon, E. et al. (2003). Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine. Antiviral Therapy 8, 531-4.
51. Orito, E., Ichida, T., Sakugawa, H. et al. (2001). Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 34, 590-4.
52. Ishikawa, K., Koyama, T. & Masuda, T. (2002). Prevalence of HBV genotypes in asymptomatic carrier residents and their clinical characteristics during long-term follow-up: the relevance to changes in the HBeAg/anti-HBe system. Hepatology Research 24, 1-7.